Bioanalytical Systems, Inc. To Host Fourth Quarter Conference Call Friday, December 17.WEST LAFAYETTE West Lafayette, city (1990 pop. 25,907), Tippecanoe co., W Ind., a suburb of Lafayette, on the Wabash River; inc. 1924. A primarily residential city, it is the seat of Purdue Univ. , Ind IND Investigational new drug Therapeutics A status assigned by the FDA to a drug before allowing its use in humans, exempting it from premarketing approval requirements so that experimental clinical trials may be conducted. See Phase 1.2, 3 studies, Sponsorship. . -- Bioanalytical Systems (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :BASI) announced today that the company will host a conference call on Friday Friday: see Sabbath; week. Friday young Indian rescued by Crusoe and kept as servant and companion. [Br. Lit.: Robinson Crusoe] See : Servant , December 17 to discuss its fourth quarter 2004 financial results for the period ended September 30, 2004. A press release announcing the results will be issued after market close on December 16, 2004. Peter Kissinger, Chairman and Chief Executive Officer; Michael Cox The name Michael Cox could refer to:
To participate, please dial the teleconferencing number shown below five minutes prior to the scheduled conference time.
Date: Friday, December 17, 2004
Time: 9:00 a.m. Eastern Time
8:00 a.m. Central Time
7:00 a.m. Mountain Time
6:00 a.m. Pacific Time
Dial-In Numbers: 800.275.3939 (Domestic)
1.973.409.9259 (International)
A live Webcast of the conference call will be available at
www.bioanalytical.com.
For those unable to participate a replay will be available
from Friday, December 17 at 11:00 a.m. ET, through
11:59 p.m. ET on Friday, December 24, 2004. To listen to
the replay, please dial:
Domestic: 877.519.4471
International: 1.973.341.3080
Replay Pin Code: 5496000
A replay of the Webcast will also be available at
www.bioanalytical.com.
BASi is a pharmaceutical development company providing contract research services and monitoring instruments to the world's leading drug development and medical device companies. The company focuses on developing innovative services and products that increase efficiency and reduce the cost of taking a new drug to market. Visit www.bioanalytical.com for more about BASi. This release contains forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. that are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to the development of products and services, changes in technology, industry standards and regulatory standards, and various market and operating risks Operating risk The inherent or fundamental risk of a firm, without regard to financial risk. The risk that is created by operating leverage. Also called business risk. detailed in the company's filings with the Securities and Exchange Commission. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion